The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes.
Highlights include:
- The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transparency and accountability
- Why effective AI governance requires cross-functional collaboration and continuous trade-off assessment
- How leveraging AI to enhance workflows can drive efficiency and effectiveness but must be implemented thoughtfully with the right controls in place
Transforming Biopharma